Items where Author is "Ringel, Florian"

Article

Guresir, Erdem and Lampmann, Tim and Brandecker, Simon and Czabanka, Marcus and Fimmers, Rolf and Gempt, Jens and Haas, Patrick and Haj, Amer and Jabbarli, Ramazan and Kalasauskas, Darius and Konig, Ralph and Mielke, Dorothee and Nemeth, Robert and Oppong, Marvin Darkwah and Pala, Andrej and Prinz, Vincent and Ringel, Florian and Roder, Constantin and Rohde, Veit and Schebesch, Karl-Michael and Wagner, Arthur and Coch, Christoph and Vatter, Hartmut (2022) PrImary decompressive Craniectomy in AneurySmal Subarachnoid hemOrrhage (PICASSO) trial: study protocol for a randomized controlled trial. TRIALS, 23 (1): 1027. ISSN , 1745-6215

Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim Peter and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortmann, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Kowalski, Thomas and Ringel, Florian and Schmidt-Graf, Friederike and Suchorska, Bogdana and Brehmer, Stefanie and Weyerbrock, Astrid and Renovanz, Miriam and Bullinger, Lars and Galldiks, Norbert and Vajkoczy, Peter and Misch, Martin and Vatter, Hartmut and Stuplich, Moritz and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Schaub, Christina and Stummer, Walter and Tonn, Joerg-Christian and Simon, Matthias and Keil, Vera C. and Nelles, Michael and Urbach, Horst and Coenen, Martin and Wick, Wolfgang and Weller, Michael and Fimmers, Rolf and Schmid, Matthias and Hattingen, Elke and Pietsch, Torsten and Coch, Christoph and Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. LANCET, 393 (10172). pp. 678-688. ISSN 0140-6736, 1474-547X

Schaefer, Niklas and Proescholdt, Martin and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Grauer, Oliver and Goldbrunner, Roland and Friedrich, Franziska and Rohde, veit and Ringel, Florian and Schlegel, Uwe and Sabel, Michael and Ronellenfitsch, Michael W. and Uhl, Martin and Grau, Stefan and Haenel, Mathias and Schnell, Oliver and Krex, Dietmar and Vajkoczy, Peter and Tabatabai, Ghazaleh and Mack, Frederic and Schaub, Christina and Tzaridis, Theophilos and Niessen, Michael and Kebir, Sied and Leutgeb, Barbara and Urbach, Horst and Belka, Claus and Stummer, Walter and Glas, Martin and Herrlinger, Ulrich (2018) Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. NEURO-ONCOLOGY, 20 (7). pp. 975-985. ISSN 1522-8517, 1523-5866

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Rohde, Veit and Ringel, Florian and Schlegel, Uwe and Sabel, Michael and Ronellenfitsch, Michael W. and Uhl, Martin and Maciaczyk, Jaroslaw and Grau, Stefan and Schnell, Oliver and Haenel, Mathias and Krex, Dietmar and Vajkoczy, Peter and Gerlach, Ruediger and Kortmann, Rolf-Dieter and Mehdorn, Maximilian and Tuettenberg, Jochen and Mayer-Steinacker, Regine and Fietkau, Rainer and Brehmer, Stefanie and Mack, Frederic and Stuplich, Moritz and Kebir, Sied and Kohnen, Ralf and Dunkl, Elmar and Leutgeb, Barbara and Proescholdt, Martin and Pietsch, Torsten and Urbach, Horst and Belka, Claus and Stummer, Walter and Glas, Martin (2016) Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. JOURNAL OF CLINICAL ONCOLOGY, 34 (14). 1611-U134. ISSN 0732-183X, 1527-7755

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Stockhammer, Florian and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Glas, Martin (2013) Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): LBA2000. ISSN 0732-183X, 1527-7755

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Stockhammer, Florian and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Glas, Martin (2013) Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-nonmethylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. JOURNAL OF CLINICAL ONCOLOGY, 31 (18supp): LBA2000. ISSN 0732-183X, 1527-7755

Rasper, Michael and Schaefer, Andrea and Piontek, Guido and Teufel, Julian and Brockhoff, Gero and Ringel, Florian and Heindl, Stefan and Zimmer, Claus and Schlegel, Juergen (2010) Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. NEURO-ONCOLOGY, 12 (10). pp. 1024-1033. ISSN 1522-8517

Conference or Workshop Item

Weller, Johannes and Zeyen, Thomas and Schlegel, Uwe and Lazaridis, Lazaros and Werner, Jan-Michael and Onken, Julia and Zeiner, Pia and Drexler, Richard and Hau, Peter and Seidel, Clemens and Grosse, Lucia and Clusmann, Hans and Sabel, Michael and Ringel, Florian and Pichler, Josef and Grauer, Oliver and Hundsberger, Thomas and Schnell, Oliver and Mair, Maximilian J. and Uhl, Martin and Schmidt-Graf, Friederike and Glas, Martin and Galldiks, Norbert and Unteroberdoerster, Meike and Steinbach, Joachim and Ricklefs, Franz and Renovanz, Mirjam and Delev, Daniel Ivanov and Turgut, Merih O. and Flesch, Oliver R. and Cipriani, Debora and Preusser, Matthias and Kebir, Sied and Misch, Martin and Goldbrunner, Roland and Westphal, Manfred and Tabatabai, Ghazaleh and Schaefer, Niklas and Schneider, Matthias and Vatter, Hartmut and Giordano, Frank and Schaub, Christina and Herrlinger, Ulrich (2022) CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT. In: 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 16-20, 2022, Tampa Bay, FL.

Weller, Johannes and Waha, Andreas and Schneider, Matthias and Seidel, Clemens and Steinbach, Joachim and Hau, Peter and Schlegel, Uwe and Tonn, Joerg-Christian and Grauer, Oliver and Sabel, Michael and Krex, Dietmar and Schnell, Oliver and Ringel, Florian and Tabatabai, Ghazaleh and Goldbrunner, Roland and Radbruch, Alexander and Schuss, Patrick and Gueresir, Erdem and Vatter, Hartmut and Glas, Martin and Schmid, Matthias and Schafer, Niklas and Tzaridis, Theophilos and Giordano, Frank and Zeyen, Thomas and Schaub, Christina and Nemeth, Robert and Pietsch, Torsten and Herrlinger, Ulrich (2021) DNA METHYLATION-BASED SUBGROUPING PREDICTS SURVIVAL BENEFIT FROM LOMUSTINE/TEMOZOLOMID COMBINATION THERAPY IN MGMT PROMOTOR-METHYLATED GLIOBLASTOMA. In: 26th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 18-21, 2021, Boston, MA.

Other

Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortman, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Tabatabai, Ghazaleh and Ringel, Florian and Schmidt-Graf, Friederike and Brehmer, Stefanie and Weyerbrock, Astrid and Bullinger, Lars and Vajkoczy, Peter and Vatter, Hartmut and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Stummer, Walter and Simon, Matthias and Keil, Vera and Nelles, Michael and Fimmers, Rolf and Pietsch, Torsten and Hattingen, Elke and Coch, Christoph and Glas, Martin (2017) PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial. OXFORD UNIV PRESS INC, CARY.

Herrlinger, Ulrich and Schaefer, Nildas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Rohde, Veit and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Gies, Martin (2014) Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.